Table 4.
Drug use in women and men living in a nursing home or at home
| Drug groups | Women (n = 31,078) | Men (n = 20,152) | Women vs men | |||||
|---|---|---|---|---|---|---|---|---|
| H | NH | H | NH | H | NH | |||
| % | % | RRa (95% CI) | % | % | RRa (95% CI) | RRb (95% CI) | RRb (95% CI) | |
| Opioids | 25.7 | 48.6 | 2.3 (2.2, 2.4) | 18.3 | 38.7 | 2.2 (2.0, 2.5) | 1.2 (1.2, 1.2) | 1.1 (1.1, 1.2) |
| Paracetamol | 22.4 | 73.6 | 3.3 (3.2, 3.4) | 12.0 | 67.7 | 5.9 (5.5, 6.3) | 1.3 (1.3, 1.3) | 1.1 (1.0, 1.2) |
| Antiepileptic drugs | 4.1 | 8.5 | 2.1 (1.8, 2.5) | 3.9 | 12.6 | 3.4 (2.7, 4.3) | 1.0 (1.0, 1.1) | 0.9 (0.8, 1.0) |
| Dopaminergic agents | 1.2 | 3.2 | 2.6 (2.0, 3.4) | 1.8 | 6.3 | 3.7 (2.7, 5.2) | 0.8 (0.8, 1.0) | 0.8 (0.7, 1.0) |
| Antipsychotics | 4.7 | 17.1 | 3.7 (3.3, 4.1) | 2.9 | 17.5 | 6.2 (5.1, 7.6) | 1.2 (1.1, 1.2) | 1.0 (0.9, 1.1) |
| Anxiolytics | 20.1 | 49.2 | 2.5 (2.3, 2.6) | 10.5 | 45.9 | 4.6 (4.1, 5.0) | 1.3 (1.2, 1.3) | 1.0 (1.0, 1.1) |
| Hypnotics/sedatives | 34.3 | 49.1 | 1.4 (1.4, 1.5) | 20.2 | 49.5 | 2.6 (2.3, 2.8) | 1.3 (1.2, 1.3) | 1.0 (1.0, 1.1) |
| Antidepressants | 13.8 | 33.0 | 2.4 (2.2, 2.6) | 7.3 | 27.7 | 3.9 (3.4, 4.5) | 1.3 (1.2, 1.3) | 1.1 (1.0, 1.1) |
| Antidementia drugs | 2.2 | 10.8 | 5.0 (4.3, 5.8) | 1.8 | 13.7 | 8.0 (6.4, 0.1) | 1.1 (1.0, 1.1) | 0.9 (0.9, 1.0) |
| Cardiac glycosides | 3.2 | 5.7 | 1.8 (1.5, 2.2) | 3.2 | 5.9 | 1.9 (1.4, 2.7) | 1.0 (1.0, 1.0) | 1.0 (0.9, 1.1) |
| Cardiac nitrates | 7.1 | 15.8 | 2.2 (2.0, 2.5) | 8.2 | 14.1 | 1.8 (1.5, 2.2) | 0.9 (0.9, 1.0) | 1.0 (1.0, 1.1) |
| Loop diuretics | 14.7 | 32.2 | 2.2 (2.0, 2.4) | 12.9 | 29.9 | 2.4 (2.1, 2.8) | 1.1 (1.0, 1.1) | 1.0 (1.0, 1.1) |
| Other diuretics | 7.5 | 3.0 | 0.4 (0.3, 0.5) | 5.3 | 2.3 | 0.5 (0.3, 0.8) | 1.2 (1.1, 1.2) | 1.1 (0.9, 1.2) |
| Beta-blockers | 27.1 | 25.1 | 0.9 (0.9, 1.0) | 32.1 | 23.6 | 0.8 (0.7, 0.9) | 0.9 (0.9, 0.9) | 1.0 (1.0, 1.1) |
| Calcium channel blockers | 19.2 | 9.5 | 0.5 (0.4, 0.6) | 20.1 | 7.6 | 0.4 (0.3, 0.5) | 1.0 (0.9, 1.0) | 1.1 (1.0, 1.1) |
| Renin–angiotensin | 40.1 | 17.9 | 0.4 (0.4, 0.5) | 42.6 | 20.7 | 0.5 (0.4, 0.6) | 1.0 (0.9, 1.0) | 1.0 (0.9, 1.0) |
| Statins | 31.8 | 4.7 | 0.1 (0.1, 0.2) | 39.7 | 9.2 | 0.2 (0.2, 0.3) | 0.9 (0.8, 0.9) | 0.8 (0.7, 0.9) |
| Antithrombotic agents | 42.7 | 42.0 | 1.0 (0.9, 1.0) | 54.6 | 50.1 | 1.0 (0.9, 1.0) | 0.8 (0.8, 0.8) | 0.9 (0.9, 1.0) |
| Inhalators | 18.6 | 17.8 | 1.0 (1.0, 1.1) | 16.5 | 23.1 | 1.0 (1.0, 1.0) | 1.1 (1.0, 1.1) | 0.9 (0.9, 1.0) |
| Corticosteroids | 11.1 | 6.3 | 0.6 (0.5, 0.7) | 8.9 | 7.4 | 0.9 (0.6, 1.2) | 1.1 (1.1, 1.1) | 1.0 (0.9, 1.1) |
| Antihistamines | 13.6 | 7.6 | 0.6 (0.5, 0.7) | 8.7 | 9.9 | 1.2 (0.9, 1.5) | 1.2 (0.2, 1.2) | 0.9 (0.8, 1.0) |
| Drugs for peptic ulcer | 18.2 | 21.7 | 1.2 (1.1, 1.3) | 15.7 | 20.0 | 1.3 (1.1, 1.6) | 1.1 (1.1, 1.1) | 1.0 (1.0, 1.1) |
| Antidiabetics | 8.5 | 8.6 | 1.0 (0.9, 1.2) | 12.8 | 11.7 | 0.9 (0.7, 1.2) | 0.8 (0.8, 0.8) | 0.9 (0.8, 1.0) |
| Osteoporosis drugs | 9.8 | 2.6 | 0.3 (0.2, 0.4) | 1.4 | 0.7 | 0.5 (0.2, 1.4) | 1.6 (1.6, 1.0) | 1.2 (1.1, 1.3) |
| NSAIDs | 22.7 | 5.6 | 0.6 (0.5, 0.7) | 17.8 | 5.2 | 0.3 (0.2, 0.4) | 1.1 (1.0, 1.1) | 1.0 (0.9, 1.1) |
H (home population), NH (nursing home population). RR (relative risk with 95% confidence interval)
Number of women (H = 29,326, NH = 1752) and men (H = 19,618, NH = 554)
aRR values calculated using the home population as the reference group
bRR values calculated using women as the reference group